Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review. - Wikidata - awgldk - TriplyDB

Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review.

Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review.

http://www.wikidata.org/entity/Q37998417

about

Generic versus brand-name drugs used in cardiovascular diseases A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation.Rational use of generic psychotropic drugs.Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective.Likelihood approach for evaluating bioequivalence of highly variable drugs.Electroacupuncture-induced attenuation of experimental epilepsy: a comparative evaluation of acupoints and stimulation parameters.Substitutes of Prescription Medicines - A Review of Concerns Relevant to Doctors and Patients.Does substitution of brand name medications by generics differ between pharmacotherapeutic classes? A population-based cohort study in France.Medical and economic factors influencing generic drug use in the Japanese public health system: Influencing factors in different populations.

P2860

Q26775920-5C778112-01AE-452D-BD01-EBE90EA20A3A Q34536861-5D4405AD-AA0F-41BB-9ED2-9E685C872234 Q34672296-6A2C8BCC-84BC-4EFE-B4FA-3D4D08D3F98C Q34688387-7D02A1B6-0284-4203-821B-9BB339E66B8C Q35763872-02D9863D-C797-439E-B6D1-A92811883868 Q35786205-612D60FA-C1E7-4065-80A2-78BA808D69EE Q36754965-2D3DE786-5BD3-488D-8689-5240D20A4525 Q42029035-6DFEC9A1-6479-4F56-AFE5-D9A041D6FBB2 Q48107325-26756EE5-3037-4DC5-8765-4031C5407D58 Q48281893-39509507-C1DB-4590-95DD-8C20E3492562

P2860

Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review.

http://www.wikidata.org/entity/Q37998417

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Efficacy and safety of innovat ...... epilepsy: a systematic review.

@en

Efficacy and safety of innovat ...... epilepsy: a systematic review.

@nl

type

label

Efficacy and safety of innovat ...... epilepsy: a systematic review.

@en

Efficacy and safety of innovat ...... epilepsy: a systematic review.

@nl

prefLabel

Efficacy and safety of innovat ...... epilepsy: a systematic review.

@en

Efficacy and safety of innovat ...... epilepsy: a systematic review.

@nl

P1433

Q37998417-E99BDE8B-A0CD-4C5B-AA62-7AE420EFBC71

P1476

Q37998417-8CB1C323-1861-46D2-AB16-08610E279178

P2093

Q37998417-2333C64A-DC53-47DF-B78D-D17A0771326D

Q37998417-5574F63E-D1DA-4C5C-9BD7-D6AC9E015509

Q37998417-7D085EB1-C4BC-408A-94C4-43E5FFD56595

Q37998417-938029C6-DC24-4874-B508-662A472C80D7

Q37998417-A5FD7B60-321B-4221-AEBA-C22FA20AE26E

Q37998417-B4F8FA63-BF0A-4998-A49F-3E2C06777F2A

Q37998417-B53AF61F-4EC5-4752-8382-21689AB4A72D

Q37998417-E4AF963C-6240-4D7D-8E57-C4DBADC15A86

P2860

Q37998417-02B7C842-B6E7-4C69-87BD-97A16E0233C5

Q37998417-46AEC5D7-926A-466B-A7BF-9ADC2314D87A

Q37998417-4919999D-0E58-4FAC-B938-892AD29376D7

Q37998417-588EDEF0-8E35-4F13-A317-A230688E0403

Q37998417-5EDD1E88-A145-4525-992A-44ABB556FB06

Q37998417-5F457D2B-1ED1-477F-A2B7-332E0BB93318

Q37998417-6F297A94-9E7E-43AD-8484-3AA9D9966407

Q37998417-77EFA966-3D04-41B8-AB11-1C6400892D9C

Q37998417-79B976CE-6F83-404C-A545-8699AE258DFD

Q37998417-881A1867-F432-4A54-91A6-9C22C87621BF

P304

Q37998417-445EC174-14AC-4BF9-9D98-CEF5B841CC0E

P31

Q37998417-16BC8365-D299-4242-A590-CDEE4080E95C

Q37998417-e5ce14ed-a629-4549-9fc8-9ceeb602fa9b

P356

Q37998417-55FC4DC5-595F-4284-8658-FBB6AE9D7B46

P407

Q37998417-3093E37D-9C48-4FFD-B1D1-7195AAAB3CED

P433

Q37998417-2BCD1D11-E144-4A5D-8FD8-CC1311AD4BF0

P478

Q37998417-008D04E4-F6B9-4069-ABC5-E362C661CD23

P50

Q37998417-F2C679E6-544B-4789-819B-3D73977C6C01

P577

Q37998417-CB77BC34-2318-49F2-A565-5083B3891877

P698

Q37998417-EDCFF75F-4FA8-409C-B724-D1395D52D8BF

P356

J.1875-9114.2012.01099.X

P1433

Pharmacotherapy

P1476

Efficacy and safety of innovat ...... epilepsy: a systematic review

@en

P2093

C Michael White

http://www.w3.org/2001/XMLSchema#string

Craig I Coleman

http://www.w3.org/2001/XMLSchema#string

Erika L Baker

http://www.w3.org/2001/XMLSchema#string

Jeffrey Kluger

http://www.w3.org/2001/XMLSchema#string

Jennifer M Scholle

http://www.w3.org/2001/XMLSchema#string

Olivia P Phung

http://www.w3.org/2001/XMLSchema#string

Ripple Talati

http://www.w3.org/2001/XMLSchema#string

William L Baker

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis in clinical trials

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.

Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries.

The risks and costs of multiple-generic substitution of topiramate.

Generic antiepileptic drugs and associated medical resource utilization in the United States.

Comparison of steady-state blood levels of two carbamazepine formulations.

Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.

Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs.

Patterns of care, outcomes, and direct health plan costs of antiepileptic therapy: a pharmacoeconomic analysis of the available carbamazepine formulations.

P304

314-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/J.1875-9114.2012.01099.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22461121

http://www.w3.org/2001/XMLSchema#string